Clinical trial / 2007
In a pilot study, 40 g of daily crushed flaxseed for 6 weeks reduced hot flash frequency and scores in women not taking estrogen.
A phase 2 pilot study assessed the tolerability and effect of 40 g of daily crushed flaxseed for 6 weeks in 30 women experiencing at least 14 hot flashes per week. After treatment, the mean decrease in hot flash scores was 57% (median decrease 62%), and the mean reduction in daily hot flash frequency was 50% (median reduction 50%), decreasing from 7.3 to 3.6 hot flashes. Mild or moderate abdominal distention occurred in 14 of 28 participants (50%), mild diarrhea in 8 (29%), flatulence in one, and six participants (21%) withdrew because of toxicities.
- Study type
- Phase 2 pilot clinical trial
- Who was studied
- 30 women not wishing to receive estrogen therapy and having at least 14 hot flashes per week for at least 1 month
- What was measured
- Change in hot flash score and daily hot flash frequency, tolerability, toxicity, and health-related quality of life
THE PAPER
Pilot evaluation of flaxseed for the management of hot flashes.
Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL. J Soc Integr Oncol, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.